Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$0.96
$0.010.82%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 87.22M | 98.83M | 117.29M | 114.79M | 90.01M |
| Total Depreciation and Amortization | 20.63M | 20.19M | 18.95M | 19.50M | 15.58M |
| Total Amortization of Deferred Charges | 596.60K | 596.60K | 596.60K | 596.60K | 885.70K |
| Total Other Non-Cash Items | 23.33M | 28.69M | 30.46M | 39.50M | 54.31M |
| Change in Net Operating Assets | -25.39M | 11.84M | -9.35M | -16.51M | -20.15M |
| Cash from Operations | 106.38M | 160.15M | 157.94M | 157.88M | 140.64M |
| Capital Expenditure | -25.00M | -20.16M | -16.65M | -14.17M | -9.51M |
| Sale of Property, Plant, and Equipment | 619.40K | 717.90K | 762.00K | 809.30K | 742.80K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.81M | -20.91M | -23.79M | -24.40M | -45.53M |
| Cash from Investing | -19.57M | -40.34M | -39.67M | -37.76M | -54.30M |
| Total Debt Issued | 5.13B | 5.24B | 4.63B | 4.28B | 4.38B |
| Total Debt Repaid | -4.37B | -4.52B | -4.16B | -4.24B | -4.34B |
| Issuance of Common Stock | 1.68B | 1.68B | 1.68B | 1.68B | 1.78B |
| Repurchase of Common Stock | -1.75B | -1.72B | -1.72B | -1.70B | -1.89B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -39.69M | -29.04M | -41.13M | -42.86M | -44.72M |
| Other Financing Activities | -821.81M | -862.79M | -853.26M | -826.61M | -791.22M |
| Cash from Financing | -46.54M | -38.61M | -63.28M | -85.96M | -93.83M |
| Foreign Exchange rate Adjustments | -8.86M | -3.38M | 4.71M | 4.86M | 9.71M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.41M | 77.81M | 59.69M | 39.02M | 2.22M |